Sugi Predict

Sugi Predict / Compounds / SCHEMBL86088

SCHEMBL86088

SCHEMBL86088

CCS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ PSIP1 O75475 2/20 0.61
▸ GAA P10253 3/20 0.60
▸ KMT2A Q03164 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ CA12 O43570 1/20 0.54
▸ CA1 P00915 1/20 0.54
▸ CA2 P00918 1/20 0.54
▸ CA3 P07451 1/20 0.54
▸ CA6 P23280 1/20 0.54
▸ CA5A P35218 1/20 0.54
▸ CA7 P43166 1/20 0.54
▸ CA9 Q16790 1/20 0.54
▸ CA5B Q9Y2D0 1/20 0.54
▸ CTSK P43235 1/20 0.53
▸ TLR9 Q9NR96 1/20 0.52
▸ MCHR1 Q99705 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28807859 0.93 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP2C9CYP2C19PSIP1
SCHEMBL10455034 0.89 PSIP1 (0.74) ALDH1A1CYP3A4CYP2C9CYP2C19PSIP1
SCHEMBL41372 0.84 ALDH1A1 (0.82) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL63945 0.84 ALDH1A1 (0.67) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL92881 0.83 ALDH1A1 (0.72) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL10702838 0.82 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL8788972 0.82 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL13564611 0.82 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL3628081 0.80 ALDH1A1 (0.61) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL3394800 0.80 ALDH1A1 (0.61) ALDH1A1CYP3A4CYP2C9CYP2C19GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1074 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100560548-C Adopt ionic liquid synthetic as phase-transfer catalyst 18The method of F mark positron radioactivity tracer agent GUO QIYONG THE SECOND HOSPITAL (CN) 2009-11-18 — — CN claimed
US-5300143-A Water soluble dye, sulfone, and amide or cyclic amine XEROX CORPORATION (US) 1994-04-05 — — US claimed
US-4101590-A COUNTERCURRENT EXTRACTION MARUZEN OIL CO., LTD. (JP) 1978-07-18 — — US claimed
CN-120118068-A Chemical process for preparing phenylpiperidinyl indole derivatives 诺华股份有限公司 2025-06-10 — — CN disclosed
CN-112513025-B Chemical process for preparing phenylpiperidinyl indole derivatives 诺华股份有限公司 2025-03-25 — — CN disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 — — US disclosed
US-20230398140-A1 OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL UNIVERSITY OF YAMANASHI (JP) 2023-12-14 — — US disclosed
US-20230398140-A1 OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL UNIVERSITY OF YAMANASHI (JP) 2023-12-14 — — US disclosed
US-20230357173-A1 PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES SUPERNUS PHARMACEUTICALS, INC. (US) 2023-11-09 — — US disclosed
US-11773228-B2 Chemically modified anion exchange membrane and method of preparing the same DANKOOK UNIVERSITY CHEONAN CAMPUS INDUSTRY ACADEMIC COOPERATION FOUNDATION 2023-10-03 — — US disclosed
WO-2023159307-A1 POLO-LIKE KINASE 4 (PLK4) INHIBITORS, PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF REPARE THERAPEUTICS INC. (CA) 2023-08-31 — — WO disclosed
EP-0500639-B1 PROCESS FOR THE PRODUCTION OF ALKYL-(3-CHLOROPHENYL) SULPHONES HOECHST AG (DE) 1994-08-03 — — EP disclosed
EP-0602914-A1 Ink compositions for ink jet printing XEROX CORPORATION (US) 1994-06-22 — — EP disclosed
US-5300143-A Water soluble dye, sulfone, and amide or cyclic amine XEROX CORPORATION (US) 1994-04-05 — — US disclosed
US-5241120-A PROCESS FOR THE PREPARATION OF ALKYL 3-CHLOROPHENYL SULFONES HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-31 — — US disclosed
EP-0500639-A1 PROCESS FOR THE PRODUCTION OF ALKYL-(3-CHLOROPHENYL) SULPHONES. HOECHST AG (DE) 1992-09-02 — — EP disclosed
WO-1991007384-A1 PROCESS FOR THE PRODUCTION OF ALKYL-(3-CHLOROPHENYL) SULPHONES HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-30 — — WO disclosed
US-4420433-A REACTION WITH SILICON TETRACHLORIDE OR TITANIUM TETRACHLORIDE BAYER AKTIENGESELLSCHAFT (DE) 1983-12-13 — — US disclosed
EP-0071065-A1 Process for the preparation of fluorine-substituted carboxylic-acid chlorides and aldehydes BAYER AG (DE) 1983-02-09 — — EP disclosed
US-4101590-A COUNTERCURRENT EXTRACTION MARUZEN OIL CO., LTD. (JP) 1978-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230398140-A1 OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL CRYAA, PDE6A, CRYAB ALDH1A1 860/4885CYP3A4 1033/4885CYP2C9 899/4885
US-20230357173-A1 PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES UGT2B7, CYP3A7, CYP3A4 ALDH1A1 727/4885CYP3A4 3/4885CYP2C9 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.